Chronic ganglioside treatment counteracts the biochemical signs of dopamine receptor supersensitivity induced by chronic haloperidol treatment
- 1 October 1983
- journal article
- research article
- Published by Elsevier in Neuroscience Letters
- Vol. 40 (3) , 293-297
- https://doi.org/10.1016/0304-3940(83)90054-x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Gangliosides increase the survival of lesioned nigral dopamine neurons and favour the recovery of dopaminergic synaptic function in striatum of rats by collateral sprouting*Acta Physiologica Scandinavica, 1983
- On the functional role of coexistence of 5‐HT and substance P in bulbospinal 5‐HT neurons. Substance P reduces affinity and increases density of3H‐5‐HT binding sitesActa Physiologica Scandinavica, 1983
- Dopamine-mediated behaviour and 3H-spiperone binding to striatal membranes in rats after nine months haloperidol administrationLife Sciences, 1980
- Dopaminergic supersensitivity after neuroleptics: Time-course and specificityPsychopharmacology, 1978
- 3H-spiroperidol labels dopamine receptors in pituitary and brainEuropean Journal of Pharmacology, 1977
- Dopaminergic supersensitivity in striatum and olfactory tubercle following chronic administration of haloperidol of clozapineLife Sciences, 1977
- Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazinePsychopharmacology, 1975
- Behavioral evidence for dopaminergic supersensitivity after chronic haloperidolLife Sciences, 1974
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951